Drugs

http://www.thestreet.com/tsc/v2008/photos/thestreet/front/lead/rx/pills2-front-lead.jpg

ASCO Abstract Preview: ImClone, Genentech

The American Society of Clinical Oncology, for the first time, is making research abstracts freely available to everyone ahead of the cancer drug confab. Here's a cheat sheet.

05/08/08 - 06:59 AM EDT

Acquisition Charges Hit Celgene

But the biotech beats Wall Street estimates on an adjusted basis, when factoring out expenses related to Pharmion.

05/08/08 - 10:18 AM EDT

FDA Panel Against Expansion of Cephalon's Fentora

The panel votes 17-3 against wider use of the pain drug.

05/06/08 - 05:36 PM EDT

These Funds Hoard Big-Volume Stocks

Some managers are gravitating toward shares of firms such as GE and Apple.

05/07/08 - 09:06 AM EDT

Onyx's Strong Quarter Bolsters New CEO

Tony Coles' tenure got off to the right start with strong earnings and meaningful financial guidance.

Article

Onyx Pharma Swings to Outsized Profit

The biotech company trounces Wall Street expectations for the first quarter on sales gains of Nexavar.

05/06/08 - 05:09 PM EDT

Article

Monday's Winners & Losers: Yahoo!

Shares fall 15% after the company's buyout by Microsoft falls apart.

05/05/08 - 04:37 PM EDT

Article

Kass: Buffett Gets a Free Pass

Berkshire Hathaway traffics in derivatives -- instruments of which Buffett has consistently been critical.

05/05/08 - 11:59 AM EDT

Article

Discovery Labs Holds Out Hope for Surfaxin

The stock Monday regains some of its sharp Friday losses on the company's positive response to FDA delays. But is the reaction overly optimistic?

05/05/08 - 11:53 AM EDT

Article

This Week's Barron's Roundup

Getting bullish on Melco Entertainment, General Dynamics and Time Warner, plus much more.

05/04/08 - 10:25 AM EDT

Article

Weekend Reading: Goodbye Microhoo!

Gauging how far Yahoo! shares will fall, plus much more required financial reading.

05/04/08 - 02:16 PM EDT

Article

Feuerstein's Biotech-Stock Mailbag

Outlooks for SuperGen's Dacogen and Myriad Genetics' Flurizan; more Q&A on ImClone's Erbitux, and more.

05/03/08 - 11:10 AM EDT

Article

Bristol Sells ConvaTec Unit for $4.1 Billion

A group of pricate equity firms is buying the wound care business in a deal expected to close in the third quarter.

05/02/08 - 04:54 PM EDT

Article

Friday's Winners & Losers: Yahoo!

Shares rise 6.9% on more merger rumors.

05/02/08 - 04:25 PM EDT

Article

FDA Approval Delay Sinks Discovery Labs

Surfaxin receives an approvable letter, but the additional delays that accompany it send shares plummeting in premarket trading.

05/02/08 - 08:22 AM EDT

Video

Altucher: End-of-the-World Stocks

James Altucher describes winning stocks for a doomed planet.

05/01/08 - 11:52 AM EDT

Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Financial Tools

Financial Glossary

Enhance your investing education as you read articles on TheStreet.com. Look for the symbol throughout our site to look up items. Browse Glossary

Check a Rating

How does your portfolio rate? Enter a ticker below or go straight to our screeners: Stocks| ETFs| Funds